Carissa Ann Raposa, LPN in Barre, MA - Licensed Practical Nurse

Carissa Ann Raposa, LPN is a Licensed Practical Nurse based in Barre, Massachusetts. Carissa Ann Raposa is licensed to practice in Massachusetts (license number LN88900) and her current practice location is 176 Cut Off Rd, Barre, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (978) 790-7639.

NPI number for Carissa Ann Raposa is 1609443373 and her current mailing address is 176 Cut Off Rd, Barre, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1609443373.

Contact Information

	Carissa Ann Raposa, LPN
	176 Cut Off Rd, Barre, MA 01005-9508
	(978) 790-7639
	Not Available

Provider's Profile

Full Name	Carissa Ann Raposa
Gender	Female
Speciality	Licensed Practical Nurse
Location	176 Cut Off Rd, Barre, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1609443373
Provider Enumeration Date: 06/09/2021
Last Update Date: 06/09/2021

Medical Identifiers

Medical identifiers for Carissa Ann Raposa such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1609443373	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	LN88900 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Carissa Ann Raposa is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Carissa Ann Raposa, LPN 176 Cut Off Rd, Barre, MA 01005-9508 Ph: (978) 790-7639	Carissa Ann Raposa, LPN 176 Cut Off Rd, Barre, MA 01005-9508 Ph: (978) 790-7639

News Archive

Brits get serious about drinking and depression

Experts in the UK are warning that the favorite ritual of a glass of wine at the end of a stressful working day is for many a form of "self-medication" and a substitute for seeking professional help with their problems.

Already available drug accelerates healing process after hip fracture

An already available drug can help patients get back on their feet more rapidly after a hip fracture, according to an international study published in the Journal of Bone Joint Surgery.

First long-acting injectable HIV treatment appraised and approved by NICE

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Extremely premature babies should not be given drug to prevent fatal fungal infection

In most circumstances, extremely premature babies should not be given a drug to prevent a potentially fatal fungal infection, according to findings by a Duke Medicine-led research team.

Carissa Ann Raposa, LPN - Licensed Practical Nurse in Barre, MA